0FUD47Z
Supplement Pancreatic Duct to No Qualifier with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | F Hepatobiliary System and Pancreas |
| Operation | U Supplement |
| Body Part | D Pancreatic Duct |
| Approach | 4 Percutaneous Endoscopic |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures add biological or synthetic material to reinforce or augment hepatobiliary or pancreatic tissue that's still in place, rather than replacing or repairing it outright. Examples include applying mesh or a biologic patch to reinforce a fragile area of liver capsule after a partial excision, or buttressing a pancreatic anastomosis with additional material to reduce the risk of a postoperative leak.
Surgeons turn to these techniques when native tissue is structurally weak, at risk of failure, or benefits from added support to hold a repair together, particularly around suture lines and areas prone to leakage of bile or pancreatic fluid. This differs from simply repairing a defect because material beyond the patient's own tissue is deliberately introduced to strengthen the area going forward.
Anatomy & Axis Detail
Pancreatic Duct
The pancreatic duct, or duct of Wirsung, runs the length of the gland and merges with the common bile duct at the ampulla, and its wall may need reinforcement after traumatic disruption, surgical repair of a leak, or correction of a pseudocyst communication. Supplementation involves adding autologous tissue, such as a jejunal serosal patch in a pancreaticojejunostomy revision, or nonautologous material to bolster the ductal wall at a vulnerable anastomotic or repair site, reducing the risk of a pancreatic fistula. Because pancreatic secretions are highly enzymatic and can digest surrounding tissue if they leak, documentation should clarify the reinforcement material and location along the duct, distinguishing supplementation of the existing duct from a more extensive bypass or diversion procedure.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Coding & Documentation
Coders should look for explicit mention of a graft, mesh, or biologic patch placed to reinforce or bolster existing tissue, since Supplement requires that the underlying body part remains and is only being strengthened. The material used and its placement site should be documented clearly enough to assign the correct device character. A recurring error is coding Supplement when the material actually substituted for excised tissue rather than reinforcing tissue left behind, which belongs under Replacement instead, so coders need to confirm whether any of the original structure was removed.